Document is current
Any future updates will be listed below
-
Authors
Davidson, Jaime A. https://orcid.org/0000-0001-8542-3528
Stager, William
Paranjape, Sachin
Berria, Rachele
Leiter, Lawrence A.
-
Funding
Funding for this research was provided by:
Sanofi (N/A)
- License Information
-
More Information
Article History
Received: 7 December 2018
Accepted: 12 August 2019
First Online: 14 January 2020
Ethics approval and consent to participate
: All patients consented to participate in the clinical trials used for this post-hoc analysis.
: Not applicable
: JAD has been a consultant or served on the advisory board for Amgen Inc., Aspire Bariatrics, AstraZeneca, Boston Therapeutics, Eli Lilly & Co., GSK, Janssen Pharmaceuticals, Merck & Co., Inc., Novo Nordisk, and Valeritas; has been a speaker for AstraZeneca, Janssen, Merck-Serono, Novo Nordisk, and Takeda; and has received a research grant from AstraZeneca. WS, SP, and RB are employees and stockholders of Sanofi. LAL. has been a consultant for AstraZeneca, Boehringer Ingelheim, Eli Lilly & Co., Janssen, Merck & Co., Inc., Novo Nordisk, Sanofi, and Servier; has received research support from AstraZeneca, Boehringer Ingelheim, Eli Lilly & Co., GlaxoSmithKline, Janssen, Merck & Co., Inc., Novo Nordisk, and Sanofi; and has provided continuing medical education on behalf of AstraZeneca, Boehringer Ingelheim, Eli Lilly & Co., Janssen, Merck & Co., Inc., Novo Nordisk, Sanofi, and Servier.
